Regoli D, Nguyen Q T, Jukic D
Department of Pharmacology, Medical School, Université de Sherbrooke, Québec, Canada.
Life Sci. 1994;54(26):2035-47. doi: 10.1016/0024-3205(94)00712-8.
Neurokinin receptors have been characterized by biological assays using naturally occurring and selective agonists as well as peptide and non peptide antagonists. Six preparations have been used: the rabbit vena cava and the rat urinary bladder, treated with a NK-2 receptor antagonist for the NK-1 receptor, the rabbit pulmonary artery and the hamster urinary bladder for the NK-2, the rat portal vein and the guinea pig ileum, treated with a NK-1 receptor antagonist, for the NK-3. Treatment with antagonists was required because of the presence (in some preparations) of two functional sites contributing to the biological effect. Differences in the order of potency of agonists between each couple of receptors have been demonstrated, especially with tachykinins and the selective agonists. Such differences are even more evident with antagonists, some of which show apparent affinity (pA2) values 1.5 to 3 log units higher in one than in the other member of each couple. Based on data obtained in pharmacological experiments, it is concluded that NK-1, NK-2 and NK-3 receptors show differences strong enough to justify the assumption that their coding and/or expression diverge among species.
神经激肽受体已通过生物测定法得以表征,该方法使用天然存在的和选择性激动剂以及肽类和非肽类拮抗剂。已使用六种制剂:用NK - 2受体拮抗剂处理过以针对NK - 1受体的兔腔静脉和大鼠膀胱;用于NK - 2的兔肺动脉和仓鼠膀胱;用NK - 1受体拮抗剂处理过以针对NK - 3的大鼠门静脉和豚鼠回肠。由于(在某些制剂中)存在两个对生物效应有贡献的功能位点,所以需要用拮抗剂进行处理。已证明每对受体之间激动剂效力顺序存在差异,尤其是对于速激肽和选择性激动剂而言。拮抗剂的这种差异更为明显,其中一些拮抗剂在每对受体的其中一个上显示出的表观亲和力(pA2)值比另一个高1.5至3个对数单位。根据药理学实验获得的数据,得出结论:NK - 1、NK - 2和NK - 3受体显示出足够大的差异,足以证明假设其编码和/或表达在不同物种间存在差异是合理的。